Veerhealth Care Ltd — Updates, 20-05-2025: Company Update

Veerhealth Care Limited has announced a board meeting on the successful closure of the USFDA inspection, qualifying the company to export OTC drug products to the US market. This milestone opens opportunities for expanded exports amid favorable tariff conditions compared to China. The company expects monthly US export orders of ₹2.5-3 Cr, potentially boosting revenues and profits. Veerhealth Care, a key player in Ayurvedic and personal care segments with a USFDA-approved plant, plans to operate at full capacity to meet rising domestic and international demand. The company also aims to enter the medical device segment in the US soon.